as of 12-05-2025 3:40pm EST
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | BOTHELL |
| Market Cap: | 1.2B | IPO Year: | 1989 |
| Target Price: | $31.50 | AVG Volume (30 days): | 375.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $19.10 - $29.62 | Next Earning Date: | 11-06-2025 |
| Revenue: | $100,144,000 | Revenue Growth: | 87.53% |
| Revenue Growth (this year): | 20.67% | Revenue Growth (next year): | 14.13% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
President and CEO
Avg Cost/Share
$25.33
Shares
31,165
Total Value
$789,409.45
Owned After
389,998
SEC Form 4
President and CEO
Avg Cost/Share
$25.88
Shares
33,418
Total Value
$864,857.84
Owned After
389,998
SEC Form 4
President and CEO
Avg Cost/Share
$26.15
Shares
35,417
Total Value
$926,154.55
Owned After
389,998
SEC Form 4
Director
Avg Cost/Share
$28.99
Shares
1,666
Total Value
$48,297.34
Owned After
44,986
SEC Form 4
President and CEO
Avg Cost/Share
$27.30
Shares
37,795
Total Value
$1,031,803.50
Owned After
389,998
SEC Form 4
Chief Technology Officer
Avg Cost/Share
$27.82
Shares
275
Total Value
$7,650.50
Owned After
26,037
SEC Form 4
Director
Avg Cost/Share
$0.00
Shares
1,334
Total Value
$0.00
Owned After
44,986
SEC Form 4
Chief Human Resources Officer
Avg Cost/Share
$27.36
Shares
188
Total Value
$5,143.68
Owned After
77,169
SEC Form 4
Chief Marketing Officer
Avg Cost/Share
$27.36
Shares
289
Total Value
$7,907.04
Owned After
133,617
SEC Form 4
Chief Quality and Operations
Avg Cost/Share
$27.36
Shares
419
Total Value
$11,463.84
Owned After
193,253
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| DE GREEF RODERICK | BLFS | President and CEO | Nov 13, 2025 | Sell | $25.33 | 31,165 | $789,409.45 | 389,998 | |
| DE GREEF RODERICK | BLFS | President and CEO | Nov 12, 2025 | Sell | $25.88 | 33,418 | $864,857.84 | 389,998 | |
| DE GREEF RODERICK | BLFS | President and CEO | Nov 11, 2025 | Sell | $26.15 | 35,417 | $926,154.55 | 389,998 | |
| GOSWAMI JOYDEEP | BLFS | Director | Oct 24, 2025 | Sell | $28.99 | 1,666 | $48,297.34 | 44,986 | |
| DE GREEF RODERICK | BLFS | President and CEO | Oct 22, 2025 | Sell | $27.30 | 37,795 | $1,031,803.50 | 389,998 | |
| Werner Sean | BLFS | Chief Technology Officer | Oct 20, 2025 | Sell | $27.82 | 275 | $7,650.50 | 26,037 | |
| GOSWAMI JOYDEEP | BLFS | Director | Oct 16, 2025 | Sell | $0.00 | 1,334 | $0.00 | 44,986 | |
| Aebersold Sarah | BLFS | Chief Human Resources Officer | Oct 9, 2025 | Sell | $27.36 | 188 | $5,143.68 | 77,169 | |
| Berard Todd | BLFS | Chief Marketing Officer | Oct 9, 2025 | Sell | $27.36 | 289 | $7,907.04 | 133,617 | |
| Foster Karen A. | BLFS | Chief Quality and Operations | Oct 9, 2025 | Sell | $27.36 | 419 | $11,463.84 | 193,253 |
See how BLFS stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "BLFS BioLife Solutions Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.